Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

How safe is it in the United States to be born someplace other than a hospital? The question has long been the focus of emotional debate and conflicting information. Now, Oregon scientists and health workers who deliver babies have some research evidence that sheds a bit more light.

Copyright 2015 NPR. To see more, visit http://www.npr.org/.

Transcript

STEVE INSKEEP, HOST:

Copyright 2015 NPR. To see more, visit http://www.npr.org/.

Transcript

RENEE MONTAGNE, HOST:

It's a typical morning at the Dupont Veterinary Clinic in Lafayette, La. Dr. Phillip Dupont is caring for cats and dogs in the examining room while his wife, Paula, answers the phone and pet owners' questions. Their two dogs are sleeping on the floor behind her desk.

"That's Ken and Henry," Paula says, pointing to the slim, midsize dogs with floppy ears and long snouts. Both dogs are tan, gray and white, with similar markings. "I put a red collar on Ken and a black collar on Henry so I can tell who's who."

Larry Goldstein is trying to find drugs to treat Alzheimer's disease. A biologist in cellular and molecular medicine at the University of California, San Diego, Goldstein also just started testing something he hopes will enable paralyzed people to walk again.

For both lines of research, he's using cells from aborted fetuses.

"The fetal cells are vital at this time because, to our knowledge, they have the best properties for the kinds of experiments that we need to do," Goldstein says.

Copyright 2015 NPR. To see more, visit http://www.npr.org/.

Transcript

AUDIE CORNISH, HOST:

The Food and Drug Administration approved the first drug designed to increase a woman's libido.

The controversial decision was hailed by some doctors and advocates as a long-sought victory for women's health, but was condemned by others as irresponsible and dangerous.

A new technology called CRISPR could allow scientists to alter the human genetic code for generations. That's causing some leading biologists and bioethicists to sound an alarm.

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

The Food and Drug Administration is considering revising a ban on blood donations from men who have had sex with other men.

An FDA advisory committee Tuesday mulled the issues raised by changing the policy, which has been in effect since the early 1980s.

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

AUDIE CORNISH, HOST:

For the first time ever, scientists are reporting that human embryonic stem cells may be helping treat patients. In the medical journal The Lancet, researchers describe how the cells seem to help restore eyesight to some blind people.

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

RACHEL MARTIN, HOST:

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

DAVID GREENE, HOST:

A prominent scientist has started a big new debate about breast cancer. Geneticist Mary-Claire King of the University of Washington, who identified the first breast cancer gene, is recommending that all women get tested for genetic mutations that can cause breast cancer.

The World Health Organization is revisiting a question that's been the subject of intense debate for decades: whether to destroy the only known samples of the smallpox virus.

Scientists reported Thursday they had figured out a way to make primitive human sperm out of skin cells, an advance that could someday help infertile men have children.

"I probably get 200 emails a year from people who are infertile, and very often the heading on the emails is: Can you help me?" says Renee Reijo Pera of Montana State University, who led the research when she was at Stanford University.

Transcript

ROBERT SIEGEL, HOST:

This is ALL THINGS CONSIDERED from NPR News. I'm Robert Siegel.

MELISSA BLOCK, HOST:

And I'm Melissa Block.

A panel of government advisers has expressed serious concerns about a controversial proposal to allow scientists to try to make babies using eggs that have been genetically altered to include DNA from another woman.

Members of the Food and Drug Administration panel said they were worried that not enough research has been done to know whether the experiments would be safe.

When Melissa Shenewa and her husband imagined their first weeks with their new baby, they pictured hours of cuddling. Instead, they're enduring hours of inconsolable crying.

Their 6-week-old son, Aladdin, is a colicky baby. He cries for hours, usually in the middle of the night. They've tried everything they could think of. Nothing helps.

"Being a parent when your child is screaming in pain for hours on end and there's nothing you can do, you feel helpless," says Shenewa, 24, who lives in Houston. "You feel like you're not a good parent."

After spending months working on a series of stories about the trillions of friendly microbes that live in and on our bodies, I decided it might be interesting to explore my own microbiome.

So I pulled out my credit card and paid the $99 needed to sign up for the American Gut Project, one of a couple of "citizen science" or crowdsourced microbiome projects.

Scientists have discovered new clues about how microbes in our digestive systems may affect health.

European researchers found that the less diverse those microbes are, the more likely people are to gain weight, become obese and develop risk factors for serious health problems.

Evidence has been mounting in recent years that bacteria and other organisms in our bodies do a lot more than just help us digest food.

A burst of brain activity just after the heart stops may be the cause of so-called near-death experiences, scientists say.

The insight comes from research involving nine lab rats whose brains were analyzed as they were being euthanized. Researchers discovered what appears to be a momentary increase in electrical activity in the brain associated with consciousness.

Although the experiment relied on animals, the results could apply to humans, too, the researchers say.

Most of the microbes in our guts appear to remain stable for years, perhaps even most of our lives, researchers reported Thursday.

Japanese scientists have cracked open a freaky new chapter in the sci-fi-meets-stem-cells era. A group in Yokohama reported it has grown a primitive liver in a petri dish using a person's skin cells.

The organ isn't complete. It's missing a few parts. And it will be years --maybe decades — before the technique reaches clinics.

The nation's organ transplant network will consider a controversial proposal Monday to overhaul the guidelines for an increasingly common form of organ donation.

The board of directors of the United Network for Organ Sharing will open a two-day meeting at the organization's headquarters in Richmond, Va., to consider new guidelines for donation after cardiac death.

Donation after cardiac death involves removing organs minutes after life-support has been stopped for patients who still have at least some brain activity.

Scientists have completed an unusual survey: a census of the fungi that inhabit different places on our skin. It's part of a big scientific push to better understand the microbes that live in and on our bodies.

"This is the first study of our fungi, which are yeast and other molds that live on the human body," says Julie Segre, of the National Human Genome Research Institute, who led the survey.

Scientists say they have, for the first time, cloned human embryos capable of producing embryonic stem cells.

The accomplishment is a long-sought step toward harnessing the potential power of embryonic stem cells to treat many human diseases. But the work also raises a host of ethical concerns.

Scientists have discovered what may be an important new risk factor for heart disease. And here's the surprising twist: The troublesome substance seems to be a waste product left behind by bacteria in our guts as they help us digest lecithin — a substance plentiful in red meat, eggs, liver and certain other foods.

Doctors say the research further illustrates the complicated relationship we have with the microbes living inside us, and could lead to new ways to prevent heart attacks and strokes.

Scientists reported Wednesday that they had developed a way to measure how much pain people are experiencing by scanning their brains.

The researchers hope the technique will help doctors treat pain better, but the work is also raising concerns about whether the technique might interfere with doctors simply listening to their patients.

Now, when someone is in pain, a doctor has no way to judge its severity except to ask questions, a method that often is inadequate.

Scientists say they have found a way to get a glimpse of people's dreams.

"Our results show that we can predict what a person's seeing during dreams," says Yukiyasu Kamitani, a researcher at the ATR Computational Neuroscience Laboratories in Kyoto, Japan.

Philosophers, poets and psychologists have long shared a fascination with dreams. But Jack Gallant, a neuroscientist at the University of California, Berkeley says solving the mystery of our dreams is one tough problem.

Pages